Skip to main content
Immune Tolerance Network

Developing, funding and conducting clinical trials in immune tolerance

Share This
Home

An NIH-sponsored clinical trial for people with primary membranous nephropathy
 

REBOOT is currently enrolling patients

  • Home
  • About Primary NM
  • About REBOOT
  • Am I Eligible?
  • Study Locations

Am I Eligible?

You may be eligible to participate in REBOOT if you:

  • Are 18 to 75 years old
  • Have been diagnosed with primary membranous neuropathy

Find a REBOOT Study location near you.

  • About ITN
  • Other ITN Studies
  • Patient Rights & Informed Consent
  • Understanding Clinical Trials

REBOOT is being conducted by the Immune Tolerance Network and sponsored by the National Institute of Allergy and Infectious Diseases (NIH funded).

NIH National Institute of Allergy and Infectious Diseases

Mobile Menu

  • Home
  • About Primary Membranous Nephropathy
  • About REBOOT
  • Am I Eligible?
  • Study Locations
  • About ITN
  • Other ITN Studies
  • Patient Rights & Informed Consent
  • Understanding Clinical Trials